102 related articles for article (PubMed ID: 12071749)
1. Toward computing relative configurations: 16-epi-latrunculin B, a new stereoisomer of the actin polymerization inhibitor latrunculin B.
Hoye TR; Ayyad SE; Eklov BM; Hashish NE; Shier WT; El-Sayed KA; Hamann MT
J Am Chem Soc; 2002 Jun; 124(25):7405-10. PubMed ID: 12071749
[TBL] [Abstract][Full Text] [Related]
2. A new dimension to the biosynthetic products isolated from the sponge Negombata magnifica.
Vilozny B; Amagata T; Mooberry SL; Crews P
J Nat Prod; 2004 Jun; 67(6):1055-7. PubMed ID: 15217296
[TBL] [Abstract][Full Text] [Related]
3. Bioactive natural and semisynthetic latrunculins.
El Sayed KA; Youssef DT; Marchetti D
J Nat Prod; 2006 Feb; 69(2):219-23. PubMed ID: 16499319
[TBL] [Abstract][Full Text] [Related]
4. Semisynthetic latrunculin B analogs: studies of actin docking support a proposed mechanism for latrunculin bioactivity.
Kudrimoti S; Ahmed SA; Daga PR; Wahba AE; Khalifa SI; Doerksen RJ; Hamann MT
Bioorg Med Chem; 2009 Nov; 17(21):7517-22. PubMed ID: 19800245
[TBL] [Abstract][Full Text] [Related]
5. Latrunculin alters the actin-monomer subunit interface to prevent polymerization.
Morton WM; Ayscough KR; McLaughlin PJ
Nat Cell Biol; 2000 Jun; 2(6):376-8. PubMed ID: 10854330
[No Abstract] [Full Text] [Related]
6. Interrogating the bioactive pharmacophore of the latrunculin chemotype by investigating the metabolites of two taxonomically unrelated sponges.
Amagata T; Johnson TA; Cichewicz RH; Tenney K; Mooberry SL; Media J; Edelstein M; Valeriote FA; Crews P
J Med Chem; 2008 Nov; 51(22):7234-42. PubMed ID: 18942825
[TBL] [Abstract][Full Text] [Related]
7. Latrunculin with a highly oxidized thiazolidinone ring: structure assignment and actin docking.
Ahmed SA; Odde S; Daga PR; Bowling JJ; Mesbah MK; Youssef DT; Khalifa SI; Doerksen RJ; Hamann MT
Org Lett; 2007 Nov; 9(23):4773-6. PubMed ID: 17929935
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of actin polymerization by latrunculin A.
Coué M; Brenner SL; Spector I; Korn ED
FEBS Lett; 1987 Mar; 213(2):316-8. PubMed ID: 3556584
[TBL] [Abstract][Full Text] [Related]
9. Quantitative determination of latrunculins A and B in the Red Sea sponge Negombata magnifica by high performance liquid chromatography.
Khalifa S; Ahmed S; Mesbah M; Youssef D; Hamann M
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 832(1):47-51. PubMed ID: 16431167
[TBL] [Abstract][Full Text] [Related]
10. A reassignment of (-)-mycothiazole and the isolation of a related diol.
Sonnenschein RN; Johnson TA; Tenney K; Valeriote FA; Crews P
J Nat Prod; 2006 Jan; 69(1):145-7. PubMed ID: 16441088
[TBL] [Abstract][Full Text] [Related]
11. Semisynthetic latrunculin derivatives as inhibitors of metastatic breast cancer: biological evaluations, preliminary structure-activity relationship and molecular modeling studies.
Khanfar MA; Youssef DT; El Sayed KA
ChemMedChem; 2010 Feb; 5(2):274-85. PubMed ID: 20043312
[TBL] [Abstract][Full Text] [Related]
12. Magnificines A and B, Antimicrobial Marine Alkaloids Featuring a Tetrahydrooxazolo[3,2-a]azepine-2,5(
Youssef DTA; Asfour HZ; Genta-Jouve G; Shaala LA
Mar Drugs; 2021 Apr; 19(4):. PubMed ID: 33921326
[TBL] [Abstract][Full Text] [Related]
13. Effects of latrunculin A on immunological phagocytosis and macrophage spreading-associated changes in the F-actin/G-actin content of the cells.
Oliveira CA; Kashman Y; Mantovani B
Chem Biol Interact; 1996 Mar; 100(2):141-53. PubMed ID: 8646787
[TBL] [Abstract][Full Text] [Related]
14. Absolute stereochemistry of amphidinolide E.
Kubota T; Tsuda M; Kobayashi J
J Org Chem; 2002 Mar; 67(5):1651-6. PubMed ID: 11871898
[TBL] [Abstract][Full Text] [Related]
15. Latrunculin A is a potent inducer of aggregation of polymorphonuclear leukocytes.
Oliveira CA; Chedraoui S; Mantovani B
Life Sci; 1997; 61(6):603-9. PubMed ID: 9250716
[TBL] [Abstract][Full Text] [Related]
16. Effects of rhizopodin and latrunculin B on the morphology and on the actin cytoskeleton of mammalian cells.
Gronewold TM; Sasse F; Lünsdorf H; Reichenbach H
Cell Tissue Res; 1999 Jan; 295(1):121-9. PubMed ID: 9931358
[TBL] [Abstract][Full Text] [Related]
17. Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells.
Sayed KA; Khanfar MA; Shallal HM; Muralidharan A; Awate B; Youssef DT; Liu Y; Zhou YD; Nagle DG; Shah G
J Nat Prod; 2008 Mar; 71(3):396-402. PubMed ID: 18298079
[TBL] [Abstract][Full Text] [Related]
18. Actin-latrunculin A structure and function. Differential modulation of actin-binding protein function by latrunculin A.
Yarmola EG; Somasundaram T; Boring TA; Spector I; Bubb MR
J Biol Chem; 2000 Sep; 275(36):28120-7. PubMed ID: 10859320
[TBL] [Abstract][Full Text] [Related]
19. Latrunculins--novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D.
Spector I; Shochet NR; Blasberger D; Kashman Y
Cell Motil Cytoskeleton; 1989; 13(3):127-44. PubMed ID: 2776221
[TBL] [Abstract][Full Text] [Related]
20. Total syntheses of the actin-binding macrolides latrunculin A, B, C, M, S and 16-epi-latrunculin B.
Fürstner A; De Souza D; Turet L; Fenster MD; Parra-Rapado L; Wirtz C; Mynott R; Lehmann CW
Chemistry; 2007; 13(1):115-34. PubMed ID: 17091520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
